Clinical Drug Experience Knowledgebase

aflibercept (zaltrap) (2 trials)

anastrozole (arimidex) (2 trials)

atezolizumab (Tecentriq) (1 trial)

bacille calmette-guerin (1 trial)

bevacizumab (avastin) (9 trials)

capecitabine (xeloda) (7 trials)

carboplatin (paraplatin) (2 trials)

celecoxib (celebrex) (1 trial)

clodronate (2 trials)

cyclophosphamide (cytoxan) (20 trials)

docetaxel (taxotere) (11 trials)

doxorubicin (Doxil) (17 trials)

epirubicin (ellence) (5 trials)

exemestane (aromasin) (3 trials)

fam-trastuzumab deruxtecan-nxki (Enhertu) (1 trial)

Filgrastim (neupogen) (1 trial)

floxuridine (fudr) (2 trials)

fluorouracil (efudex) (15 trials)

gemcitabine (gemzar) (3 trials)

heparin (liquaemin) (1 trial)

ibandronate (boniva) (1 trial)

irinotecan (Camptosar) (3 trials)

lapatinib (tykerb) (1 trial)

letrozole (femara) (4 trials)

leucovorin (9 trials)

levamisole (ergamisol) (1 trial)

octreotide (sandostatin) (1 trial)

oxaliplatin (eloxatin) (11 trials)

paclitaxel (taxol) (13 trials)

palbociclib (ibrance) (4 trials)

raloxifene (evista) (1 trial)

regorafenib (stivarga) (1 trial)

rosuvastatin (crestor) (1 trial)

semustine (1 trial)

tamoxifen (nolvadex) (7 trials)

tegafur (1 trial)

trastuzumab (herceptin) (9 trials)

trastuzumab emtansine (kadcyla) (3 trials)

triptorelin (Trelstar) (1 trial)

uracil (1 trial)

veliparib (1 trial)

vincristine (oncovin) (1 trial)

zoledronic acid (zometa) (1 trial)

ae37 peptide vaccine (1 trial)

cetuximab (erbitux) (4 trials)

cixutumumab (1 trial)

durvalumab (imfinzi) (2 trials)

eribulin (halaven) (1 trial)

gefitinib (iressa) (1 trial)

gevokizumab (1 trial)

goserelin (zoladex) (1 trial)

nerlynx (5 trials)

panitumumab (vectibix) (1 trial)

pazopanib (votrient) (1 trial)

pembrolizumab (keytruda) (2 trials)

pertuzumab (perjeta) (1 trial)

tremelimumab (Imjudo) (1 trial)

urea (1 trial)

dexamethasone (1 trial)

folic acid (1 trial)

methylcobalamin (1 trial)

pemetrexed (alimta) (1 trial)